14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today EXEL ranks #16046 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$17.08 (-1.73%)

Volume: 2M

Closed: Jan 19, 2022

Hollow Logo Score: -4.540

Exelixis Stock Forecast

$17.08 (-1.73%)

Volume: 2M

Closed: Jan 19, 2022

Score Hollow Logo -4.540

EXEL Stock Insider Trading NASDAQ:EXEL

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -2.954.

In total, the insiders bought 1 811 876 and sold 1 907 002 EXEL shares in the last 100 trades.

INSIDER POWER

-2.954

Last 100 transactions
Buy: 1 811 876 | Sell: 1 907 002 (Shares)
Date Action Amount Person Type
Jan 04, 2022 Sell 7 613 Goodman Vicki L Common Stock
Jan 04, 2022 Buy 250 000 Goodman Vicki L Common Stock
Dec 16, 2021 Buy 41 717 Wright Jacqueline Option (right to buy)
Dec 16, 2021 Buy 20 858 Wright Jacqueline Common Stock
Dec 15, 2021 Sell 2 621 Hessekiel Jeffrey Common Stock
Dec 15, 2021 Buy 9 994 Hessekiel Jeffrey Common Stock
Dec 15, 2021 Sell 5 131 Senner Christopher J. Common Stock
Dec 15, 2021 Buy 19 491 Senner Christopher J. Common Stock
Dec 15, 2021 Sell 47 500 Lamb Peter Option (right to buy)
Dec 15, 2021 Sell 47 500 Lamb Peter Common Stock
Dec 15, 2021 Buy 47 500 Lamb Peter Common Stock
Dec 15, 2021 Sell 4 646 Lamb Peter Common Stock
Dec 15, 2021 Buy 18 741 Lamb Peter Common Stock
Dec 15, 2021 Sell 1 556 Haley Patrick J. Common Stock
Dec 15, 2021 Buy 8 995 Haley Patrick J. Common Stock
Dec 15, 2021 Sell 12 236 Morrissey Michael Common Stock
Dec 15, 2021 Buy 46 478 Morrissey Michael Common Stock
Nov 29, 2021 Buy 196 524 Morrissey Michael Common Stock
Nov 29, 2021 Sell 196 524 Morrissey Michael Common Stock
Nov 24, 2021 Sell 17 236 Haley Patrick J. Common Stock
Nov 19, 2021 Sell 20 000 Feldbaum Carl B Option (right to buy)
Nov 19, 2021 Sell 20 000 Feldbaum Carl B Common Stock
Nov 19, 2021 Buy 20 000 Feldbaum Carl B Common Stock
Nov 15, 2021 Sell 44 184 Haley Patrick J. Common Stock
Nov 15, 2021 Sell 983 Haley Patrick J. Common Stock
Nov 15, 2021 Sell 4 323 Haley Patrick J. Common Stock
Nov 15, 2021 Sell 46 743 Hessekiel Jeffrey Common Stock
Nov 15, 2021 Sell 1 311 Hessekiel Jeffrey Common Stock
Nov 15, 2021 Sell 6 557 Hessekiel Jeffrey Common Stock
Nov 15, 2021 Sell 46 920 Senner Christopher J. Common Stock
INSIDER POWER

-2.954

Last 100 transactions
Buy: 1 811 876 | Sell: 1 907 002 (Shares)

About Exelixis

Exelixis Exelixis, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of new medicines with the potential to enhance care and outcomes for people with cancer. It focuses on advancing cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, and VEGF receptors, which has shown clinical anti-tumor activity in approximately 20 forms of cancer and is the subject of a broad clinical development pr... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT